Skip to content
Screener

Other, net at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$50K+50.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$25M-327%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$607K+90.6%
IQVIA logo
IQVIAIQV
-$2.75M

Other financials

Income statement

See full
Revenue$3.7B+5.8%
Gross profit$1.1B+6.3%
Operating income$451.6M+14.5%
Net income$298.7M+25.6%
EPS (diluted)$3.64+28.2%

Balance sheet

See full
Cash & equivalents$141.8M-78.1%
Total debt$6.8B+11.8%
Total equity$8.6B+1.6%
Total assets$18.5B+2.6%

Cash flow

See full
Operating cash flow$445.5M-28.2%
CapEx$121.0M-4.0%
Free cash flow$313.9M-42.2%

Valuation

See full
Market cap$25.67B+18.4%
Enterprise value$32.29B+19.3%
P/E25.6×-2.8×
P/S1.8×+0.2×

Profitability

See full
Gross margin28.9%+0.7pp
Operating margin10.4%+1.6pp
Net margin7%+1.3pp
FCF margin8.1%-1.3pp

Returns & leverage

See full
Return on equity11.7%+2.5pp
Debt / equity0.8×+0.1×
Current ratio1.8×+0.3×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: Labcorp Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 2:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000920148-26-000139
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net proceeds from issuance of stock to employees32.925.7
Dividends paid(61.2)(61.6)
Purchase of common stock(98.0)
Other, net(3.4)(3.3)
Net cash provided by (used for) financing activities580.5(839.7)
Effect of exchange rate on changes in Cash and cash equivalents(1.1)7.9
Net increase (decrease) in Cash and cash equivalents448.8(1,149.3)
Cash and cash equivalents at beginning of period532.31,518.7

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Labcorp Holdings's other, net?
Labcorp Holdings (LH) reported other, net of -$3.4M in Q1 2026.
How has Labcorp Holdings's other, net changed year-over-year?
Labcorp Holdings's other, net decreased by 3.0% year-over-year, from -$3.3M to -$3.4M.
What is the long-term trend for Labcorp Holdings's other, net?
Over 4 years (2021 to 2025), Labcorp Holdings's other, net has grown at a -15.2% compound annual growth rate (CAGR), from -$26.5M to -$13.7M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about Labcorp Holdings's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude